GlassScriptPhysician profile
Marcela M Andersen
NPI 1871832360
$822.27
in general payments reported to CMS, 2019-2025
11 companies · $94.70 in 2025
The $94.70 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $273 · 2023: $249 · 2024: $206 · 2025: $94.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $152.90 | 2023 | Dupixent |
| Genzyme Corporation | $145.32 | 2022 | |
| Glaxosmithkline, LLC. | $127.20 | 2022 | |
| Neurelis, INC. | $118.95 | 2024 | Valtoco |
| Verrica Pharmaceuticals INC. | $86.74 | 2024 | Ycanth |
| Cumberland Pharmaceuticals, INC. | $48.04 | 2023 | Kristalose |
| Hologic Sales and Service, LLC | $44.93 | 2025 | Aptima |
| Ultragenyx Pharmaceutical INC. | $29.20 | 2023 | Crysvita |
| Sanofi-Aventis U.S. LLC | $27.47 | 2025 | |
| Novo Nordisk INC | $22.30 | 2025 | Wegovy |
| Phadia US INC. | $19.22 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcela Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.